DRUG · Unmapped registry intervention
Lamotrigine (Lamictal® (Registered Trademark)
Find medicine records ·
Find other trials using this name
Clinical trial
New Drugs in the Treatment of Mood Disorders
NCT00001482
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Gabapentin (Neurontin® (Registered Trademark))
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNew Drugs in the Treatment of Mood Disorders
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Anxiety Disorderverified · MONDO: anxiety disorder
Mood Disorderverified · MONDO: mood disorder
Psychotic Disorderverified · MONDO: psychotic disorder
Interventions
Sponsors & collaborators
National Institute of Mental Health (NIMH)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00001482 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.